tiprankstipranks
Advertisement
Advertisement

GHRS Stock Latest News

Psychedelic: Clearmind reports safety findings for CMND-100
The FlyPsychedelic: Clearmind reports safety findings for CMND-100
4d ago
CMND
CMPS
GH Research initiated with an Overweight at Wells Fargo
PremiumThe Fly
GH Research initiated with an Overweight at Wells Fargo
7d ago
GHRS
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
PremiumThe Fly
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
11d ago
LLY
ATAI
Helus Pharma price target lowered to $45 from $48 at Guggenheim
PremiumThe Fly
Helus Pharma price target lowered to $45 from $48 at Guggenheim
17d ago
LLY
ATAI
AtaiBeckley downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
AtaiBeckley downgraded to Hold from Buy at JonesResearch
17d ago
ATAI
CMPS
FDA announces availability of final guidance for psychedelic drug research
PremiumThe FlyFDA announces availability of final guidance for psychedelic drug research
19d ago
ATAI
CMND
VA, HHS sign MOU to improve cooperation on psychedelic drug trials
Premium
The Fly
VA, HHS sign MOU to improve cooperation on psychedelic drug trials
20d ago
ATAI
CMPS
Jefferies says guidance suggests FDA receptive to helping psychedelic sponsors
Premium
The Fly
Jefferies says guidance suggests FDA receptive to helping psychedelic sponsors
21d ago
ATAI
CMPS
GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM
PremiumCompany Announcements
GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM
1M ago
6K
GHRS
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
PremiumThe Fly
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
2M ago
CMND
ENVB
GH Research announces publication of Phase 2a results for mebufotenin
PremiumThe Fly
GH Research announces publication of Phase 2a results for mebufotenin
2M ago
GHRS
GH Research Publishes Positive Phase 2a Postpartum Depression Data and Secures CINP 2026 Slots for GH001
PremiumCompany Announcements
GH Research Publishes Positive Phase 2a Postpartum Depression Data and Secures CINP 2026 Slots for GH001
2M ago
6K
GHRS
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
PremiumThe FlyPsychedelic: Enveric, NRx, Bright Minds report quarterly earnings
2M ago
CMND
CMPS
GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026
Premium
Company Announcements
GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026
2M ago
6K
GHRS
GH Research price target lowered to $65 from $70 at H.C. Wainwright
Premium
The Fly
GH Research price target lowered to $65 from $70 at H.C. Wainwright
3M ago
GHRS
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
PremiumThe Fly
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
3M ago
GHRS
GH Research price target lowered to $39 from $42 at Citizens
PremiumThe Fly
GH Research price target lowered to $39 from $42 at Citizens
3M ago
GHRS
GH Research Launches $200 Million At-the-Market Share Offering With Stifel
PremiumCompany Announcements
GH Research Launches $200 Million At-the-Market Share Offering With Stifel
3M ago
6K
GHRS
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
PremiumThe Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
3M ago
ATAI
CMND
GH Research files $400M mixed securities shelf
PremiumThe FlyGH Research files $400M mixed securities shelf
3M ago
GHRS
GH Research reports Q1 EPS (31c), consensus (26c)
Premium
The Fly
GH Research reports Q1 EPS (31c), consensus (26c)
3M ago
GHRS
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
Premium
Company Announcements
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
3M ago
6K
GHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >